Literature DB >> 21279100

The etiology and management of leukopenia.

V W Ing.   

Abstract

Leukopenia is an abnormal reduction of circulating white blood cells, especially the granulocytes. The term leukopenia is often used interchangeably with neutropenia. It may result from reduced production of white blood cells or increased utilization and destruction, or both. Infection, drugs, malignancy, megaloblastosis, hypersplenism and immunoneutropenia are responsible for most cases of neutropenia. Primary neutropenia is very rare. Sometimes, particularly in children, primary neutropenia is hereditary and may be associated with other developmental defects. The major danger of neutropenia is the risk of infection. Management requires identification of the cause and effective antimicrobial therapy, especially when serious systemic infection is present.

Entities:  

Year:  1984        PMID: 21279100      PMCID: PMC2154209     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  30 in total

1.  FAMILIAL BENIGN CHRONIC NEUTROPENIA.

Authors:  H O CUTTING; J E LANG
Journal:  Ann Intern Med       Date:  1964-11       Impact factor: 25.391

2.  Megaloblastic anemia associated with anticonvulsant drugs.

Authors:  J M FLEXNER; R C HARTMANN
Journal:  Am J Med       Date:  1960-03       Impact factor: 4.965

3.  Prevalence, nature and identification of leukocyte antibodies.

Authors:  J L TULLIS
Journal:  N Engl J Med       Date:  1958-03-20       Impact factor: 91.245

4.  Chronic hypoplastic neutropenia.

Authors:  T H SPAET; W DAMESHEK
Journal:  Am J Med       Date:  1952-07       Impact factor: 4.965

Review 5.  Infectious complications in leukemic patients.

Authors:  G P Bodey; R Bolivar; V Fainstein
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

Review 6.  Bone marrow transplantation in acute leukemia.

Authors:  G W Santos; H Kaizer
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

Review 7.  Connective tissue diseases.

Authors:  A Mowat
Journal:  Clin Haematol       Date:  1972-10

Review 8.  Infection.

Authors:  J M Murdoch; C C Smith
Journal:  Clin Haematol       Date:  1972-10

9.  Cytomegalovirus infections associated with leukocyte transfusions.

Authors:  D J Winston; W G Ho; C L Howell; M J Miller; R Mickey; W J Martin; C H Lin; R P Gale
Journal:  Ann Intern Med       Date:  1980-11       Impact factor: 25.391

10.  Effect of antineoplastic drugs on human leukocyte-mediated cytotoxicity against herpes simplex virus infected cells.

Authors:  R Bolivar; S Kohl; L K Pickering; D L Walters
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

View more
  5 in total

1.  Repeat Epidural Injections of SP-102 (Dexamethasone Sodium Phosphate Injectable Gel) in Subjects with Lumbosacral Radiculopathy.

Authors:  Richard Radnovich; Jill Heinz; Chris Ambrose; Elizabeth Stannard; Dmitri Lissin
Journal:  J Pain Res       Date:  2021-05-05       Impact factor: 3.133

2.  Gemfibrozil Induces Anemia, Leukopenia and Reduces Hematopoietic Stem Cells via PPAR-α in Mice.

Authors:  Gabriel Rufino Estrela; Adriano Cleis Arruda; Heron Fernandes Vieira Torquato; Leandro Ceotto Freitas-Lima; Mauro Sérgio Perilhão; Frederick Wasinski; Alexandre Budu; Ricardo Ambrósio Fock; Edgar Julian Paredes-Gamero; Ronaldo Carvalho Araujo
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

3.  Valproate-Induced Bicytopenia: A Case Study.

Authors:  Varun Jaitpal; Sushil Gawande
Journal:  Cureus       Date:  2022-02-17

4.  Determination of etiology in patients admitted due to isolated leukopenia.

Authors:  Gulay Mart; Umit Y Malkan; Yahya Buyukasik
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Distal organ inflammation and injury after resuscitative endovascular balloon occlusion of the aorta in a porcine model of severe hemorrhagic shock.

Authors:  Yansong Li; Michael A Dubick; Zhangsheng Yang; Johnny L Barr; Brandon J Gremmer; Michael L Lucas; Corina Necsoiu; Bryan S Jordan; Andriy I Batchinsky; Leopoldo C Cancio
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.